表紙
市場調査レポート

頸部ジストニア:世界の治験レビュー

Cervical Dystonia Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 306649
出版日 ページ情報 英文 110 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.39円で換算しております。
Back to Top
頸部ジストニア:世界の治験レビュー Cervical Dystonia Global Clinical Trials Review, H1, 2014
出版日: 2014年05月30日 ページ情報: 英文 110 Pages
概要

当レポートでは、頸部ジストニアに関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7諸国およびE7(新興7カ国)における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、お届けします。

目次

イントロダクション

  • 頸部ジストニア
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域上位5ヶ国における治験件数
    • 欧州上位5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東およびアフリカの上位5ヵ国における治験件数
    • ラテンアメリカの上位5ヶ国における治験件数

G7諸国における治験件数:中枢神経系治験に対する頸部ジストニア治験件数比率

G7諸国における治験件数:フェーズ(相)別

G7諸国における治験件数:進捗状況別

E7(新興7カ国)における治験件数:中枢神経系に対する頸部ジストニアの治験件数比率

E7(新興7カ国)における治験件数:フェーズ(相)別

E7(新興7カ国)における治験件数:進捗状況別

治験件数:フェーズ(相)別

  • 進行中の治験:フェーズ別

進捗状況別の治験件数

評価項目別の治験件数

未完了の治験

一定期間に採用された被験者数

スポンサーの種類別の治験件数

有望なスポンサー

有望な薬剤

治験のプロファイル

  • 代表的企業の治験の概要
    • Ipsen S.A.
    • Merz Pharma GmbH & Co. KgaA
    • Allergan, Inc.
    • エーザイ
    • Solstice Neurosciences, Inc.
    • Medy-Tox Inc.
    • Ethicon, Inc.
    • Alphatec Holdings, Inc.
    • Allergan S.A.
  • 代表的な研究機関病院の治験の概要
    • National Institute of Neurological Disorders and Stroke
    • University of Florida
    • University Health Network
    • Medical University of Vienna
    • Seoul National University Hospital
    • The University of South Florida
    • Greenwich Hospital
    • CAMC Health System
    • Leiden University Medical Center
    • Henry Ford Health System

5つの代表的な治験のプロファイル

付録

図表一覧

目次
Product Code: GDHC2196CTIDB

GlobalData's clinical trial report, "Cervical Dystonia Global Clinical Trials Review, H1, 2014" provides data on the Cervical Dystonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cervical Dystonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cervical Dystonia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Cervical Dystonia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Cervical Dystonia to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Cervical Dystonia to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Cervical Dystonia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Cervical Dystonia Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Ipsen S.A.
      • Clinical Trial Overview of Ipsen S.A.
      • Merz Pharma GmbH & Co. KgaA
      • Clinical Trial Overview of Merz Pharma GmbH & Co. KgaA
      • Allergan, Inc.
      • Clinical Trial Overview of Allergan, Inc.
      • Eisai Co., Ltd.
      • Clinical Trial Overview of Eisai Co., Ltd.
      • Solstice Neurosciences, Inc.
      • Clinical Trial Overview of Solstice Neurosciences, Inc.
      • Medy-Tox Inc.
      • Clinical Trial Overview of Medy-Tox Inc.
      • Ethicon, Inc.
      • Clinical Trial Overview of Ethicon, Inc.
      • Alphatec Holdings, Inc.
      • Clinical Trial Overview of Alphatec Holdings, Inc.
      • Allergan S.A.
      • Clinical Trial Overview of Allergan S.A.
    • Clinical Trial Overview of Top Institutes / Government
      • National Institute of Neurological Disorders and Stroke
      • Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
      • University of Florida
      • Clinical Trial Overview of University of Florida
      • University Health Network
      • Clinical Trial Overview of University Health Network
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • The University of South Florida
      • Clinical Trial Overview of The University of South Florida
      • Greenwich Hospital
      • Clinical Trial Overview of Greenwich Hospital
      • CAMC Health System
      • Clinical Trial Overview of CAMC Health System
      • Leiden University Medical Center
      • Clinical Trial Overview of Leiden University Medical Center
      • Henry Ford Health System
      • Clinical Trial Overview of Henry Ford Health System
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Cervical Dystonia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Cervical Dystonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Cervical Dystonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Cervical Dystonia to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Cervical Dystonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Cervical Dystonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Cervical Dystonia to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Cervical Dystonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Cervical Dystonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Cervical Dystonia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Cervical Dystonia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Cervical Dystonia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Cervical Dystonia Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Cervical Dystonia Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Cervical Dystonia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2014*
  • Cervical Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharma GmbH & Co. KgaA, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2014*
  • Cervical Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014*
  • Cervical Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Solstice Neurosciences, Inc., 2014*
  • Cervical Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medy-Tox Inc., 2014*
  • Cervical Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ethicon, Inc., 2014*
  • Cervical Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Alphatec Holdings, Inc., 2014*
  • Cervical Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan S.A., 2014*
  • Cervical Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of South Florida, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Greenwich Hospital, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by CAMC Health System, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Henry Ford Health System, 2014*

List of Figures

  • Cervical Dystonia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Cervical Dystonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Cervical Dystonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Cervical Dystonia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Cervical Dystonia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Cervical Dystonia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Cervical Dystonia to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Cervical Dystonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Cervical Dystonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Cervical Dystonia to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Cervical Dystonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Cervical Dystonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Cervical Dystonia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Cervical Dystonia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Cervical Dystonia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Cervical Dystonia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Cervical Dystonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Cervical Dystonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top